Sign In
Buy MNKD
$4.13
+0.240 (+6.17%)
At Close: Jul 24, 2026
MannKind Corporation (MNKD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
07:30pm, Wednesday, 10'th Sep 2025
MannKind Corporation (NASDAQ:MNKD ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 2:35 PM EDT Company Participants Michael Castagna - CEO & Director Conference Call Partic
MannKind Corporation (MNKD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
09:55pm, Sunday, 07'th Sep 2025
MannKind Corporation (NASDAQ:MNKD ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 4:30 PM EDT Company Participants Michael Castagna - CEO & Director Conference Call Participants
MannKind Corporation (MNKD) Presents At Cantor Global Healthcare Conference 2025 Transcript
09:28pm, Sunday, 07'th Sep 2025
MannKind Corporation (NASDAQ:MNKD ) Cantor Global Healthcare Conference 2025 September 4, 2025 9:45 AM EDT Company Participants Michael Castagna - CEO & Director Conference Call Participants Olivia Br
MannKind to Present at Upcoming Investor Conferences
04:05pm, Wednesday, 27'th Aug 2025
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled
MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
08:05am, Wednesday, 27'th Aug 2025
DANBURY, Conn. and BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that United Therapeutics Corporation (Nasdaq: UTHR) has exercised its option—grante
New Strong Sell Stocks for August 27th
05:51am, Wednesday, 27'th Aug 2025
CVGI, INBK and MNKD have been added to the Zacks Rank #5 (Strong Sell) List on August 27, 2025.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of s
MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal
01:57pm, Monday, 25'th Aug 2025
MannKind Corporation MNKD on Monday agreed to acquire scPharmaceuticals Inc. SCPH for a deal value of up to approximately $360 million, or $5.35 per share.
MannKind Corporation (MNKD) Mergers and Acquisition Call Transcript
01:36pm, Monday, 25'th Aug 2025
MannKind Corporation (NASDAQ:MNKD ) Mergers and Acquisition Conference Call August 25, 2025 8:30 AM ET Company Participants Christopher B. Prentiss - Chief Financial Officer Michael E.
DANBURY, Conn. and BURLINGTON, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) and scPharmaceuticals Inc. (Nasdaq: SCPH) today announced the signing of a definitive merger
Acquisition expected to diversify and accelerate double-digit revenue growth with FUROSCIX ® , an innovative treatment for edema due to chronic heart failure and chronic kidney disease, addressing si
MannKind Corporation (MNKD) Q2 2025 Earnings Conference Call Transcript
05:20pm, Wednesday, 06'th Aug 2025
MannKind Corporation (NASDAQ:MNKD ) Q2 2025 Earnings Call August 6, 2025 9:00 AM ET Company Participants Christopher B. Prentiss - Chief Financial Officer Michael E.
MannKind Corporation: A Post-Q2 Assessment
04:44pm, Wednesday, 06'th Aug 2025
Today, we take another look at MannKind Corporation, which specializes in inhaled therapeutics for endocrine and orphan lung diseases, with a market cap of $1.15 billion. The company just reported sec
MannKind (MNKD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
10:36am, Wednesday, 06'th Aug 2025
The headline numbers for MannKind (MNKD) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimate
MannKind (MNKD) Reports Break-Even Earnings for Q2
09:26am, Wednesday, 06'th Aug 2025
MannKind (MNKD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.04. This compares to earnings of $0.05 per share a year ago.
